EVICORE SAVE

Dead / Abandoned — Abandoned — no statement of use filed (as of 12 May 2025)

What this means for you

This application is over — abandoned 12 May 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
97923385
Mark type
Stylized text
Filed
05 May 2023
Published for opposition
13 Aug 2024
Abandoned
12 May 2025
Attorney of record
Alexandra MacKay

Goods and services

  • Class 035 — Advertising and business services: Cost management for the health and prescription drug plans of others in the field of pharmaceuticals, clinical care and health care treatment; business services in the nature of pharmaceutical cost management, namely, prescription drug formulary cost management services; consulting services in the cost management of healthcare and pharmacy services; Pharmaceutical cost management services and drug utilization review services; medical cost management; managed care services, namely, utilization review and pre-certification services; evidence-based health care cost management services and healthcare utilization and review services; patient relationship management services and pharmaceutical cost management; medical and pharmaceutical cost management services in the fields of medical oncology, radiation therapy, genetic laboratory services, diagnostic radiology, inpatient admissions, cancer surgery, and healthcare services in the field of oncology; Drug utilization review services and drug formulary cost and business management services; strategic business analysis and business advice regarding pharmacy benefit management, pharmaceutical end-user behavior, healthcare use behavior; market study and analysis of market studies in the fields of healthcare, healthcare benefits, and pharmacy benefits effecting health behavior change and choice at the patient level, providing business intelligence services in the field of pharmacy benefit management; Cost management and business management of the health care benefit plans of others in the field of oncology, namely, management related to chemotherapy benefits, infusion treatment benefits, injection treatment benefits and other treatment benefits in the field of oncology; organization and coordination of health care services, namely, utilization management, prior authorization, claims adjudication, and clinical decision support for medical oncology services, radiation therapy, diagnostic radiology services, hospital admissions, and surgery
  • Class 036 — Insurance and financial services: Pharmacy benefit management services; medical benefit management services; medical and pharmacy benefit management services, namely, tracking, monitoring, assessing and analyzing information and statistics regarding patient prescription drug use, medical care, and healthcare habits, to identify potential cost savings and clinical benefits; claims administration services in the field of health insurance; medical insurance case and utilization review and insurance claims adjustment services for healthcare purchasers, payers, providers, and beneficiaries of health plans; administration of managed health care plans; insurance administration in the field of health care; insurance services, namely, administration of healthcare benefit insurance plans
  • Class 044 — Medical, beauty and agricultural services: Advisory services and consultancy in the field of healthcare; healthcare services, namely, disease management programs; consulting services in the field of health

Owner

Prosecution history

  • 12 May 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
  • 12 May 2025 — ABANDONMENT - NO USE STATEMENT FILED
  • 08 Oct 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 13 Aug 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 13 Aug 2024 — PUBLISHED FOR OPPOSITION
  • 24 Jul 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 05 Jul 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 19 Apr 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 19 Apr 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 19 Apr 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 08 Feb 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 08 Feb 2024 — NON-FINAL ACTION E-MAILED
  • 08 Feb 2024 — NON-FINAL ACTION WRITTEN
  • 30 Jan 2024 — ASSIGNED TO EXAMINER
  • 05 Jun 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

View this trademark record on Marksy